Christopher Paige insider trades: AVROBIO (AVRO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christopher reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 11, 2020 | AVRO | ↓ Sell | 15,000 | $28.00 | $420K | Direct | Feb 11, 2020 (0d) |
| Jan 28, 2020 | AVRO | ↓ Sell | 10,000 | $23.00 | $230K | Direct | Jan 30, 2020 (2d) |
| Apr 8, 2019 | AVRO | ↓ Sell | 10,000 | $25.72 | $257K | Direct | Apr 9, 2019 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Christopher Paige's insider trades
Christopher Paige is a director at AVROBIO (AVRO). Since Apr 8, 2019, Christopher has reported no open-market purchases and 3 sales worth $907K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AVRO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.